CE Mark Study for the Harpoon Medical Device

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 28, 2016

Primary Completion Date

November 6, 2017

Study Completion Date

September 6, 2022

Conditions
Mitral Valve RegurgitationMitral Valve ProlapseMitral Valve Insufficiency
Interventions
DEVICE

Harpoon Artificial ePTFE Chords

It is anticipated that use of the Harpoon device could achieve similar outcomes to open cardiac surgery while decreasing the invasiveness of mitral valve repair.

Trial Locations (4)

20132

Ospedale San Raffaele Hospital, Milan

351278

University Hospital Padova, Padua

SH3 6NP

The Royal Brompton and Harefield NHS Foundation Trust, London

SO16 6YD

University Hospital Southampton NHS Trust, Southampton

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY